Carboplatin, Gemcitabine, and Mifepristone for Advanced Breast Cancer and Recurrent or Persistent Epithelial Ovarian Cancer
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 11 Dec 2017
At a glance
- Drugs Mifepristone (Primary) ; Carboplatin; Gemcitabine
- Indications Advanced breast cancer; Fallopian tube cancer; Male breast cancer; Ovarian cancer; Peritoneal cancer
- Focus Adverse reactions
- 05 Dec 2017 Planned End Date changed from 1 Nov 2017 to 1 Jun 2018.
- 05 Dec 2017 Planned primary completion date changed from 1 Nov 2017 to 1 Jun 2018.
- 10 Jun 2017 Biomarkers information updated